logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Valuation In Life Sciences A Practical Guide 3rd Edition Boris Bogdan

  • SKU: BELL-1894916
Valuation In Life Sciences A Practical Guide 3rd Edition Boris Bogdan
$ 31.00 $ 45.00 (-31%)

5.0

68 reviews

Valuation In Life Sciences A Practical Guide 3rd Edition Boris Bogdan instant download after payment.

Publisher: Springer-Verlag Berlin Heidelberg
File Extension: PDF
File size: 5.02 MB
Pages: 370
Author: Boris Bogdan, Ralph Villiger (auth.)
ISBN: 9783642108198, 3642108199
Language: English
Year: 2010
Edition: 3

Product desciption

Valuation In Life Sciences A Practical Guide 3rd Edition Boris Bogdan by Boris Bogdan, Ralph Villiger (auth.) 9783642108198, 3642108199 instant download after payment.

This book is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. After guiding the reader through the theory of valuation, including DCF, decision trees, and real options, the authors demonstrate how to value projects, patents, licences, firms, and stocks on real-life examples, even treating complex licence and company structures. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results.

The 3rd edition of the successful work includes new studies about success rates and about drug development in the biotech industry and their influence on valuation.

Related Products